Bactiguard Holding AB (CHIX:BACTBS) Institutional Ownership: 20.17% (As of Jul. 11, 2026)


CHIX:BACTBS Bactiguard Holding AB CHIX:BACTBS
58 GF Score
Price kr128.60
GF Value kr266.73
! 2 Warning Signs
View Full Analysis

What is Bactiguard Holding AB Institutional Ownership?

Bactiguard Holding AB CHIX:BACTBS 58 Institutional Ownership is 20.17% as of Jul. 11, 2026. GuruFocus rates CHIX:BACTBS with a GF Score™ of 58/100 and a GF Value™ of kr266.73. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bactiguard Holding AB's institutional ownership is 20.17%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bactiguard Holding AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bactiguard Holding AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Bactiguard Holding AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Bactiguard Holding AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bactiguard Holding AB Institutional Ownership Chart

Bactiguard Holding AB Historical Data

The historical data trend for Bactiguard Holding AB can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 20.52 20.40 20.40 20.73 20.73 20.20 20.20 20.20 20.19 20.17
CHIX:BACTBS
58GF Score
Bactiguard Holding AB CHIX:BACTBS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bactiguard Holding AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 20.17% mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Institutional Ownership of 20.17% as of Jul. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bactiguard Holding AB and its competitors.
Is Bactiguard Holding AB's Institutional Ownership too high?
Bactiguard Holding AB's current Institutional Ownership is 20.17%. Overall, Bactiguard Holding AB has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Institutional Ownership compare to ABT and SYK?
Bactiguard Holding AB's Institutional Ownership of 20.17% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current Institutional Ownership is 20.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Institutional Ownership of 20.17%. The stock's GF Value™ is kr266.73, compared to a current price of kr128.60 — trading 51.8% below its estimated fair value. The current Institutional Ownership is 20.17%. Bactiguard Holding AB's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Institutional Ownership is 20.17% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?

Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued. The current stock price of kr128.60 is trading 51.8% below its estimated GF Value™ of kr266.73.

Key valuation signals for CHIX:BACTBS:

  • Institutional Ownership: 20.17%
  • GF Value™: kr266.73 vs. price of kr128.60 (51.8% below fair value)
  • GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bactiguard Holding AB Business Description

Other Exchanges BACTI B:Sweden5JE:Germany
Address Vasagatan 11, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
58GF Score

Get the complete analysis for CHIX:BACTBS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr128.60
Price
kr266.73
GF Value